The Oncology Institute, Inc. TOI Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivablesNetCurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- The Oncology Institute, Inc. (TOI) reported other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) of $1.32M in Q1 2026.
- How has The Oncology Institute, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) changed year-over-year?
- The Oncology Institute, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) increased by 280.3% year-over-year, from $346K to $1.32M.
- What is the long-term trend for The Oncology Institute, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) has grown at a 23.3% compound annual growth rate (CAGR), from $113K to $322K.